This list is an analysis based on recent market events. It's not an investment recommendation.
About
PlexBio Co., Ltd. is dedicated to the creation and production of in vitro diagnostic (IVD) solutions for both molecular biology and immunology purposes. Their comprehensive product range features services for optimizing diagnostic workflows, as well as automated kits for sample preparation and extraction. A key innovation is their IntelliPlex platform, which leverages pCode technology to enable advanced, "sample-to-answer" multiplexing assays. The company also supplies specialized oncology panels designed for detecting lung cancer, gene mutations, and chromosomal rearrangements. Additionally, PlexBio offers a variety of infectious disease tests, including IntelliPlex kits for SARS-CoV-2 detection, influenza, and SARS-CoV-2 variant analysis, complemented by essential reagents such as pCode coupling buffer sets. Founded in 2009, PlexBio Co., Ltd. operates from its headquarters in Taipei, Taiwan.
The current price of 6572.TWO is TWD6.30 TWD — it has increased by +1.29% in the past 24 hours. Watch PlexBio stock price performance more closely on the chart.
What is PlexBio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange PlexBio stocks are traded under the ticker 6572.TWO.
Is PlexBio stock price growing?▼
6572.TWO stock has fallen by -5.97% compared to the previous week, the month change is a -9.48% fall, over the last year PlexBio has showed a -33.61% decrease.
What is PlexBio market cap?▼
Today PlexBio has the market capitalization of 653M
What is PlexBio revenue for the last year?▼
PlexBio revenue for the last year amounts to 127.1M TWD.
What is PlexBio net income for the last year?▼
6572.TWO net income for the last year is -62.47M TWD.
How many employees does PlexBio have?▼
As of November 3, 2026, the company has 20 employees.